Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options Joel Fulton,Alison Harrod,Van Nguyen,Manikandan Periyasamy, Laura Ramos Garcia,Chun-Fui Lai,Alex de Giorgio,Gergana MetodievaBREAST CANCER RESEARCH AND TREATMENT（2016）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
